Imatinib mesylate-induced acute cytolytic hepatitis

被引:11
作者
Rocca, P [1 ]
El Jastimi, S
Troncy, J
Scoazec, JY
Boucher, A
Vial, T
Trepo, C
Zoulim, F
机构
[1] Hop Hotel Dieu, Serv Hepatogastroenterol, Lyon, France
[2] Hop Edouard Herriot, Hematol Serv, Lyon, France
[3] Hop Edouard Herriot, Lab Anatomopathol, Lyon, France
[4] Hop Edouard Herriot, Ctr Pharmacovigilance, Lyon, France
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2004年 / 28卷 / 10期
关键词
D O I
10.1016/S0399-8320(04)95160-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:918 / 919
页数:2
相关论文
共 9 条
[1]
Danan G, 2003, GASTROEN CLIN BIOL, V27, pB21
[2]
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[3]
Elliott MA, 2002, NEW ENGL J MED, V346, P712
[4]
Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J].
Heinrich, MC ;
Griffith, DJ ;
Druker, BJ ;
Wait, CL ;
Ott, KA ;
Zigler, AJ .
BLOOD, 2000, 96 (03) :925-932
[5]
Histological features of acute hepatitis after imatinib mesylate treatment [J].
James, C ;
Trouette, H ;
Marit, G ;
Cony-Makhoul, P ;
Mahon, FX .
LEUKEMIA, 2003, 17 (05) :978-979
[6]
Imatinib [J].
Lyseng-Williamson, K ;
Jarvis, B .
DRUGS, 2001, 61 (12) :1765-1774
[7]
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis [J].
Ohyashiki, K ;
Kuriyama, Y ;
Nakajima, A ;
Tauchi, T ;
Ito, Y ;
Miyazawa, K ;
Kimura, Y ;
Serizawa, H ;
Ebihara, Y .
LEUKEMIA, 2002, 16 (10) :2160-2161
[8]
Imatinib mesylate, the first molecularly targeted gene suppressor [J].
Pindolia, VK ;
Zarowitz, BJ .
PHARMACOTHERAPY, 2002, 22 (10) :1249-1265
[9]
Drug therapy: Imatinib mesylate - A new oral targeted therapy. [J].
Savage, DG ;
Antman, KH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :683-693